Renalytix Plc Performance
| RTNXFDelisted Stock | USD 0.09 0.00 0.00% |
The company holds a Beta of -0.0928, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Renalytix Plc are expected to decrease at a much lower rate. During the bear market, Renalytix Plc is likely to outperform the market. Renalytix Plc right now holds a risk of 0.0%. Please check Renalytix Plc jensen alpha and day median price , to decide if Renalytix Plc will be following its historical price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Renalytix Plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Renalytix Plc is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 65.1 M | |
| Total Cashflows From Investing Activities | -662 K |
Renalytix |
Renalytix Plc Relative Risk vs. Return Landscape
If you would invest 9.10 in Renalytix Plc on October 3, 2025 and sell it today you would earn a total of 0.00 from holding Renalytix Plc or generate 0.0% return on investment over 90 days. Renalytix Plc is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Renalytix, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Renalytix Plc Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Renalytix Plc's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Renalytix Plc, and traders can use it to determine the average amount a Renalytix Plc's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| RTNXF |
Based on monthly moving average Renalytix Plc is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Renalytix Plc by adding Renalytix Plc to a well-diversified portfolio.
Renalytix Plc Fundamentals Growth
Renalytix Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Renalytix Plc, and Renalytix Plc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Renalytix Pink Sheet performance.
| Return On Equity | -1.2 | |||
| Return On Asset | -0.63 | |||
| Operating Margin | (15.38) % | |||
| Current Valuation | 53.6 M | |||
| Shares Outstanding | 93.61 M | |||
| Price To Earning | 10.53 X | |||
| Price To Book | 2.91 X | |||
| Price To Sales | 25.80 X | |||
| Revenue | 2.97 M | |||
| EBITDA | (52.81 M) | |||
| Cash And Equivalents | 32.36 M | |||
| Cash Per Share | 0.45 X | |||
| Total Debt | 7.68 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 0.25 X | |||
| Cash Flow From Operations | (45.92 M) | |||
| Earnings Per Share | (0.60) X | |||
| Total Asset | 50.06 M | |||
About Renalytix Plc Performance
By analyzing Renalytix Plc's fundamental ratios, stakeholders can gain valuable insights into Renalytix Plc's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Renalytix Plc has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Renalytix Plc has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. Renalytix Plc was incorporated in 2018 and is headquartered in New York, New York. Renalytix Plc operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 51 people.Things to note about Renalytix Plc performance evaluation
Checking the ongoing alerts about Renalytix Plc for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Renalytix Plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Renalytix Plc is not yet fully synchronised with the market data | |
| Renalytix Plc has some characteristics of a very speculative penny stock | |
| Renalytix Plc has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 2.97 M. Net Loss for the year was (45.28 M) with profit before overhead, payroll, taxes, and interest of 874 K. | |
| Renalytix Plc has accumulated about 32.36 M in cash with (45.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 41.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Renalytix Plc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Renalytix Plc's stock is overvalued or undervalued compared to its peers.
- Examining Renalytix Plc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Renalytix Plc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Renalytix Plc's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Renalytix Plc's pink sheet. These opinions can provide insight into Renalytix Plc's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Consideration for investing in Renalytix Pink Sheet
If you are still planning to invest in Renalytix Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Renalytix Plc's history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |